You are here: Industry Insights > COVID-19

News List

Researchers find key element in human antibodies against COVID-19 expresspharma
July 15, 2020
The study results can facilitate the design of vaccine agents that can elicit a strong neutralising antibody response, say scientists.
FDI in pharma and related implications of COVID-19 expresspharma
July 15, 2020
Arvind Sharma, Partner - M&A and General Corporate, Shardul Amarchand Mangaldas & Co states that the pharma sector is well poised, and is looking forward to attract FDI and exploit the many opportunities created by COVID-19.
Sanofi and Regeneron provide update on Kevzara? (sarilumab) Phase 3 U.S. trial in COVID-19 patients worldpharmanews
July 14, 2020
Sanofi and Regeneron Pharmaceuticals, Inc. announced that the U.S. Phase 3 trial of Kevzara? (sarilumab) 400 mg in COVID-19 patients requiring mechanical ventilation did not meet its primary and key secondary endpoints when Kevzara was added to ...
Charity warns of 'catastrophic' effect of COVID-19 on stroke research pharmatimes
July 14, 2020
The Stroke Association says it has been forced to suspend three-quarters of its funded research projects because of the coronavirus pandemic, which has devastated its fund-raising capabilities.
Glenmark Pharma cuts price of COVID-19 drug by 27 pc to Rs 75/tablet expresspharma
July 14, 2020
Glenmark Pharmaceuticals had launched FabiFlu last month at a price of Rs 103 per tablet.
Biocon to launch drug for COVID-19 patients; priced at Rs 8,000 per vial expresspharma
July 14, 2020
Itolizumab is the first novel biologic therapy to be approved anywhere in the world for treating patients with moderate to severe COVID-19 complications, Biocon had earlier said in a regulatory filing.
TXA127 enters multiple Phase II trials in COVID-19 patients europeanpharmaceuticalreview
July 14, 2020
A pharmaceutical formulation of the human angiotensin peptide, TXA127, will enter Phase II trials in hospitalised COVID-19 patients not in intensive care.
Australia’s TGA approves remdesivir as first Covid-19 treatment pharmaceutical-technology
July 14, 2020
The Therapeutic Goods Administration (TGA) of Australia has awarded provisional approval for the use of Gilead Sciences’ remdesivir (Veklury) to treat Covid-19 patients, marking the first authorisation of treatment for this disease in the country.
Biocon’s drug Itolizumab gets approval to treat Covid-19 pharmaceutical-technology
July 14, 2020
Biopharmaceuticals company Biocon has secured approval from the Drugs Controller General of India (DCGI) for its plaque psoriasis drug Itolizumab (ALZUMAb) for emergency use in Covid-19 patients.
GSK, Medicago Enter COVID-19 Vax Tie-up contractpharma
July 14, 2020
Combines plant-based and adjuvant technologies to develop and produce a COVID-19 candidate vaccine.